Catalog Home Page

Primary over-expression of AβPP in muscle does not lead to the development of inclusion body myositis in a new lineage of the MCK-AβPP transgenic mouse

Luo, Y-B, Johnsen, R.D., Griffiths, L., Needham, M., Fabian, V.A., Fletcher, S., Wilton, S.D. and Mastaglia, F.L. (2013) Primary over-expression of AβPP in muscle does not lead to the development of inclusion body myositis in a new lineage of the MCK-AβPP transgenic mouse. International Journal of Experimental Pathology, 94 (6). pp. 418-425.

Link to Published Version: http://dx.doi.org/10.1111/iep.12048
*Subscription may be required
Free to read: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC394445...
*No subscription required

Abstract

The aim of this study is to determine whether primary over-expression of AβPP in skeletal muscle results in the development of features of inclusion body myositis (IBM) in a new lineage of the MCK-AβPP transgenic mouse. Quantitative histological, immunohistochemical and western blotting studies were performed on muscles from 3 to 18 month old transgenic and wild-type C57BL6/SJL mice. Electron microscopy was also performed on muscle sections from selected animals. Although western blotting confirmed that there was over-expression of full length AβPP in transgenic mouse muscles, deposition of amyloid-β and fibrillar amyloid could not be demonstrated histochemically or with electron microscopy. Additionally, other changes typical of IBM such as rimmed vacuoles, cytochrome C oxidase-deficient fibres, upregulation of MHC antigens, lymphocytic inflammatory infiltration and T cell fibre invasion were absent. The most prominent finding in both transgenic and wild-type animals was the presence of tubular aggregates which was age-related and largely restricted to male animals. Expression of full length AβPP in this MCK-AβPP mouse lineage did not reach the levels required for immunodetection or deposition of amyloid-β as in the original transgenic strains, and was not associated with the development of pathological features of IBM. These negative results emphasise the potential pitfalls of re-deriving transgenic mouse strains in different laboratories.

Publication Type: Journal Article
Publisher: Wiley
Copyright: © 2013 The Authors
URI: http://researchrepository.murdoch.edu.au/id/eprint/21858
Item Control Page Item Control Page